Clinical nutrition scores are superior for the prognosis of haemodialysis patients compared to lab markers and bioelectrical impedance

Nephrology Dialysis Transplantation

Volumn 24, Issue 12, 2009, Pages 3812-3817

  Fiedler, Roman ^a   Jehle, Peter M ^b   Osten, Bernd ^a   Dorligschaw, Otgontogoo ^a   Girndt, Matthias ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b Ev Krankenhaus Paul Gerhardt Stift   (Germany)

Author keywords

Bioelectrical impedance; Haemodialysis; Hospitalization; Mortality; Nutritional status

Indexed keywords

PREALBUMIN; SERUM ALBUMIN; TRANSFERRIN;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEMODIALYSIS; HUMAN; IMPEDANCE; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MORTALITY; NUTRITIONAL STATUS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN METABOLISM; SCORING SYSTEM; SURVIVAL RATE;

BIOLOGICAL MARKERS; ELECTRIC IMPEDANCE; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; NUTRITIONAL STATUS; PROGNOSIS; PROSPECTIVE STUDIES; RENAL DIALYSIS; SURVIVAL RATE;

EID: 71049192697     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp346     Document Type: Article

References (59)

1. Kalantar-Zadeh K, Kopple JD, Humphreys MH et al. Comparing outcome predictability of markers of malnutrition-inflammation complex syndrome in haemodialysis patients. Nephrol Dial Transplant 2004; 19: 1507-1519
2. Kaysen GA. The microinflammatory state in uremia: causes and potential consequences. J Am Soc Nephrol 2001; 12: 1549-1557
3. Stenvinkel P, Barany P, Heimbürger O et al. Mortality, malnutrition, and atherosclerosis in ESRD: what is the role of interleukin-6? Kidney Int 2002; 61(Suppl 80): S103-S108
4. Stenvinkel P, Heimbürger O, Paultre F et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 1999; 55: 1899-1911 (Pubitemid 29197978)
5. Zimmermann J, Herrlinger S, Pruy A et al. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 1999; 55: 648-658
6. FouqueD,Kalantar-ZadehK,KoppleJet al.Aproposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int 2008; 73: 391-398
7. Himmelfarb J, Hakim RM. Oxidative stress in uremia. Curr Opin Nephrol Hypertens 2003; 12: 593-598
8. Locatelli F, Canaud B, Eckardt KU et al. Oxidative stress in end-stage renal disease: an emerging threat to patient outcome. Nephrol Dial Transplant 2003; 18: 1272-1280
9. Lowrie EG. Chronic inflammation and clinical outcome in adult hemodialysis patients. Kidney Int 2002; 61(Suppl 80): S94-S98
10. Nascimento MM, Qureshi AR, Stenvinkel P et al. Malnutrition and inflammation are associated with impaired pulmonary function in patients with chronic kidney disease. Nephrol Dial Transplant 2004; 19: 1823-1828
11. Pupim LB, Caglar K, Hakim RM et al. Uremic malnutrition is a predictor of death independent of inflammatory status. Kidney Int 2004; 66: 2054-2060
12. Stenvinkel P. Anaemia and inflammation: what are the implications for the nephrologist? Nephrol Dial Transplant 2003; 18(Suppl 8): viii17-viii22
13. Zoccali C, Mallamaci F, Tripepi G. Inflammation and atherosclerosis in end-stage renal disease. Blood Purif 2003; 21: 29-36
14. Abbott KC, Glanton CW, Trespalacios FC et al. Body mass index, dialysis modality, and survival: analysis of the United States Renal Data System Dialysis Morbidity and Mortality Wave II Study. Kidney Int 2004; 65: 597-605
15. Norman K, Schütz T, Kemps M et al. The subjective global assessment reliably identifies malnutrition-related muscle dysfunction. Clin Nutr 2005; 24: 143-150
16. Esteve E, Ricart W, Fernandez-Real JM. Dyslipidemia and inflammation: an evolutionary conserved mechanism. Clin Nutr 2005; 24: 16-31
17. Kalantar-Zadeh K, Block G, Humphreys MA et al. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int 2003; 63: 793-808 (Pubitemid 36315558)
18. Pupim LB, Ikizler TA. Assessment and monitoring of uremic malnutrition. J Ren Nutr 2004; 14: 6-19
19. Avram MM, Sreedhara R, Fein P et al. Survival on hemodialysis and peritoneal dialysis over 12 years with emphasis on nutritional parameters. Am J Kidney Dis 2001; 37(Suppl 2): S77-S80
20. Don BR, Kaysen GA. Serum albumin: relationship to inflammation and nutrition. Semin Dial 2004; 17: 432-437
21. Sreedhara R, Avram MM, Blanco M et al. Prealbumin is the best nutritional predictor of survival in hemodialysis and peritoneal dialysis. Am J Kidney Dis 1996; 28: 937-942 (Pubitemid 26412093)
22. Chumlea WC. Anthropometric and body composition assessment in dialysis patients. Semin Dial 2004; 17: 466-470
23. Detsky AS, McLaughlin JR, Baker JP et al. What is the subjective global assessment of nutritional status? JPEN J Parenter Enteral Nutr 1987; 11: 8-13
24. Kondrup J, Allison SP, Elia M et al. ESPEN guidelines for nutrition screening 2002. Clin Nutr 2003; 22: 415-421
25. Kalantar-Zadeh K, Kopple JD, Block G et al. A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Dis 2001; 38: 1251-1263
26. European Best Practice Guidelines for Haemodialysis (Part 1). Nephrol Dial Transplant 2002; 17(Suppl 7): S1-S111
27. European Best Practice Guidelines for the management of anaemia in patients with chronic renal failure. Nephrol Dial Transplant 1999; 14(Suppl 5): S1-S50
28. Revised European Best Practice Guidelines for the management of anaemia in patients with chronic renal failure. Nephrol Dial Transplant 2004; 19(Suppl 2): ii1-ii47
29. Management of the renal patient. Nephrol Dial Transplant 2000; 15(Suppl 5): S1-S154
30. National Kidney Foundation. K/DOQI clinical practice guidelines: bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003; 42(Suppl 3): S1-S201
31. Daugirdas JT. Dialysis adequacy and kinetics. Curr Opin Nephrol Hypertens 2000; 9: 599-605
32. Teixeira Nunes F, de Campos G, Xavier de Paula SM et al. Dialysis adequacy and nutritional status of hemodialysis patients. Hemodial Int 2008; 12: 45-51
33. Girndt M, Kaul H, Sester U et al. Anti-inflammatory interleukin-10 genotype protects dialysis patients from cardiovascular events. Kidney Int 2002; 62: 949-955
34. Ikizler TA, Wingard RL, Harvell J et al. Association of morbidity with markers of nutrition and inflammation in chronic hemodialysis patients: a prospective study. Kidney Int 1999; 55: 1945-1951
35. Mauri JM, Cleries M, Vela E, Catalan Renal Registry. Design and validation of a model to predict early mortality in haemodialysis patients. Nephrol Dial Transplant 2008; 23: 1690-1696
36. Rambod M, Bross R, Zitterkoph J et al. Association of malnutrition-inflammation score with quality of life and mortality in hemodialysis patients: a 5-year prospective cohort study. Am J Kidney Dis 2009; 53: 298-309
37. Mushnick R, Fein PA, Mittman N et al. Relationship of bioelectrical impedance parameters to nutrition and survival in peritoneal dialysis patients. Kidney Int 2003; 64(Suppl 87): S53-S56
38. Hung CY, Chen YA, Chou CC et al. Nutritional and inflammatory parameters in the prediction of mortality in Chinese hemodialysis patients. Nephron Clin Pract 2005; 100: c20-c26
39. Nescolarde L, Piccoli A, Roman A et al. Bioelectrical impedance vector analysis in haemodialysis patients: relation between oedema and mortality. Physiol Meas 2004; 25: 1271-1280
40. Piccoli A, Pastori G, Guizzo M et al. Equivalence of information from single versus multiple frequency bioimpedance vector analysis in hemodialysis. Kidney Int 2005; 67: 301-313
41. Cooper BA, Bartlett LA, Aslani A et al. Validity of subjective global assessment as a nutritional marker in end-stage renal disease. Am J Kidney Dis 2002; 40: 126-132
42. Jones CH, Wolfenden RC, Wells LM. Is subjective global assessment a reliable measure of nutritional status in hemodialysis? J Ren Nutr 2004; 14: 26-30
43. Ho LC, Wang HH, Peng YS et al. Clinical utility of malnutrition- inflammation score in maintenance hemodialysis patients: focus on identifying the best cut-off point. Am J Nephrol 2008; 28: 840-846
44. Bilgic A, Akgul A, Sezer S et al. Nutritional status and depression, sleep disorder, and quality of life in hemodialysis patients. J Ren Nutr 2007; 17: 381-388
45. Wanner C, Krane V, März W et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 2005; 353: 238-248 (Pubitemid 41058323)
46. Colman S, Bross R, Benner D et al. The nutritional and inflammatory evaluation in dialysis patients (NIED) study: overview of the NIED study and the role of dietitians. J Ren Nutr 2005; 15: 231-243
47. Bleyer AJ. Use of antimicrobial catheter lock solutions to prevent catheter-related bacteraemia. Clin J Am Soc Nephrol 2007; 2: 1073-1078
48. Bergman M, Huikko S, Huovinen P et al. Finnish Study Group for Antimicrobial Resistance (FiRe Network). Macrolide and azithromycin use are linked to increased macrolide resistance in Streptococcus pneu-moniae. Antimicrob Agents Chemother 2006; 50: 3646-3650
49. Vascular Access Work Group. Clinical practice guidelines for vascular access. Am J Kidney Dis 2006; 48(Suppl 1): S248-S273
50. O'Grady NP, Alexander M, Dellinger EP et al. Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 2002; 35: 1281-1307 (Pubitemid 35448956)
51. Renal Association (UK). Clinical guidelines-module 3a-haemodialysis. 2007. Available at: http://www.renal.org/ guidelines/module3a. html#VascularAccess (Accessed on 14 December 2007)
52. Tordoir J, Canaud B, Haage P et al. EBPG on vascular access. Nephrol Dial Transplant 2007; 22(Suppl 2): ii88-ii117
53. Pratt RJ, Pellowe CM, Wilson JA et al. EPIC 2: national evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England. J Hosp Infect 2007; 65S: S1-S64
54. Chaiyakunapruk N, Veenstra DL, Lipsky BA et al. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis. Ann Inter Med 2002; 136: 792-801
55. Walder B, Pittet D, Tramer M. Prevention of bloodstream infections with central venous catheters treated with anti-infective agents depends on catheter type and insertion time: evidence from a meta-analysis. Infect Control Hosp Epidemiol 2002; 23: 748-756
56. Lu PL, Tsai JC, Chiu YW et al. Methicillin-resistant Staphylococ-cus aureus carriage, infection and transmission in dialysis patients, healthcare workers and their family members. Nephrol Dial Transplant 2008; 23: 1659-1665
57. Yu VL, Goetz A, Wagener M. Staphylococcus aureus carriage and infection in patients on haemodialysis. Efficacy of antibiotic prophylaxis. N Engl J Med 1986; 315: 91-96
58. Boelaert JR, De Smedt RA, De Baere YA et al. Nasal mupirocin ointment decreases the incidence of Staphylococcus aureus bacteraemias in haemodialysis patients. Nephrol Dial Transplant 1989; 4: 278-281
59. Beathard GA. Catheter management protocol for catheter-related bac-teraemia prophylaxis. Semin Dial 2003; 16: 403-405